1 – 5 of 11
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology
(
- Contribution to journal › Article
-
Mark
Self-Report Tool for Identification of Individuals With Coronary Atherosclerosis : The Swedish CardioPulmonary BioImage Study
(
- Contribution to journal › Article
- 2023
-
Mark
Age and sex differences in cause-specific excess mortality and years of life lost associated with COVID-19 infection in the Swedish population
(
- Contribution to journal › Article
-
Mark
Pulmonary embolism and deep venous thrombosis after COVID-19 : long-term risk in a population-based cohort study
(
- Contribution to journal › Article
- 2022
-
Mark
COVID-19 in people aged 18–64 in Sweden in the first year of the pandemic : Key factors for severe disease and death
(
- Contribution to journal › Article